EuBiologics Co., Ltd. 206650

KRX · South Korea · Health Technology

KRW 8,450.00-180.00 (-2.09%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

EuBiologics Co., Ltd. 206650

KRX · South Korea · Health Technology

KRW 8,450.00-180.00 (-2.09%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-36.61% · 6MFull-screen chart

Open KRW 8,620.00High KRW 8,680.00Low KRW 8,440.00Close KRW 8,450.00Volume 80.58K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: KRW 8,630.00
Day range: KRW 8,440.00 – KRW 8,680.00
52-week range: KRW 6,950.00 – KRW 17,700.00
Volume: 80.58K
Market cap: KRW 304.68B
P/E (TTM): 10.7
Next earnings date: 2026-11-06
Avg. volume (1Y): 274.97K

Performance

1 week

+0.59%

1 month

-8.83%

3 months

-2.76%

6 months

-36.41%

Year to date

-25.77%

1 year

-35.83%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: South Korea
Exchange: KRX
Shares outstanding: 36.22M
Employees: 397
ISIN: KR7206650004
Beta: 0.16

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMay 19, 2026

[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cholera Vaccine Market size & share revenue was valued at approximately USD 312 Million in 2025 and is expected to reach USD 336 Million in 2026 and is expected to reach around USD 649 Million by 2035, at a CAGR of 7.6 between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Sanofi S.A., Hilleman Laboratories, Bi

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.